Next, she was switched back to the glargine and glulisine but with the glargine insulin given twice daily. Results:The patient's HbA1c improved to 7.6% (60 mmol/mol) but with frequent episodes of hypoglycemia p
Methods: A retrospective study was conducted in adult patients admitted to the intensive care units between February 2013 and June 2017 and received insulin glargine BID or 鈮 40 units daily for 鈮 48 hours. Post cardiovascular surgery patients were excluded. Data was collected for up to 14 ...
See the Side Effects section for more details. What should I know about insulin glargine before using it? Do not use insulin glargine unless it has been prescribed to you by a healthcare provider. Use it as prescribed. This medicine is to be injected under the skin. Make sure that you ...
insulin glargine insulin glulisine insulin lispro insulin NPH insulin regular human ketoprofen ketorolac ketorolac intranasal lanthanum carbonate lapatinib lenvatinib leuprolide levofloxacin levonorgestrel oral/ethinylestradiol/ferrous bisglycinate lofexidine magnesium chloride magnesium citrate magnesium hydroxide magnesium...
insulin detemir insulin glargine insulin glulisine insulin lispro insulin NPH insulin regular human isoniazid isradipine ketoconazole levoketoconazole mesalamine mesterolone metformin methyclothiazide methyltestosterone metolazone metyrapone miglitol montelukast nateglinide nifedipine nimodipine nitrendipine oxandrolone oxyb...
Basal insulin Fc (BIF; LY3209590) is an insulin IgG Fc-fusion protein developed for once weekly dosing. The results of the first in-human studies of BIF assessing the safety, tolerability, PK, and PD following single and once-weekly doses of BIF are presented below. The single ascending ...
Background The uncertainties regarding dose similarities between basal long-acting insulin analogues remain. Recent real-world studies indicate dose similarities between insulin detemir and insulin glargine, but further studies are still warranted. The aim of this study was to compare real-life daily dos...
comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients Marie Jakobsen1*, Mette Dalsgaard1, Morten Hørmann1 and Daniél Vega Møller2 Abstract Background: The uncertainties regarding dose similarities between basal long-acting insulin analogues remain. Re...
Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients主要由Jakobsen Marie、Dalsgaard Mette、Hørmann Morten编写,在2012年被BMC Endocrine Disorders收录,
insulin glargine insulin glulisine insulin lispro insulin NPH insulin regular human ketamine lasmiditan levodopa inhaled lithium loxapine loxapine inhaled lurasidone mestranol metformin metrizamide molindone olanzapine oliceridine opium tincture paliperidone ...